Can Travelers (TRV) Retain Its Surprise Streak in Q4 Earnings?

Published on January 17, 2022

Travelers' (TRV) fourth-quarter results are likely to reflect strength across its segments.

Continue reading on website
Other news

AbbVie's (ABBV) Rinvoq Gets FDA Nod for Atopic Dermatitis

January 17, 2022
FDA approves AbbVie's (ABBV) Rinvoq for the treatment of moderate to severe atopic dermatitis in adults and children aged 12 and above. This is the third indication for Rinvoq in...

Reasons to Hold on to Montrose Environmental (MEG) Stock

January 17, 2022
Montrose Environmental Group (MEG) is benefiting from robust organic growth across service lines.